Agilus Diagnostics Ltd has, on September 29, 2023, filed the draft red herring prospectus (the "DRHP") with the Securities and Exchange Board of India. The actual timing and implementation of the IPO will be subject to the determination of the Company's and Agilus's respective boards, after considering the prevailing market conditions and other relevant factors and at such price determined in accordance with the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended, The proposed IPO shall also be subject to such regulatory approvals, as required under applicable law.
Shares of Fortis Healthcare Limited was last trading in BSE at Rs. 339.95 as compared to the previous close of Rs. 343.40. The total number of shares traded during the day was 20019 in over 1078 trades.
The stock hit an intraday high of Rs. 345.10 and intraday low of 338.30. The net turnover during the day was Rs. 6841298.00.